
Organogenesis Holdings Inc.
NASDAQ:ORGO
5.26 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||
Net Income
| 0.861 | 4.945 | 15.532 | 94.902 | 17.949 | -40.454 | -64.831 | -2.094 | -0.209 | -24.261 |
Depreciation & Amortization
| 17.026 | 23.449 | 18.031 | 16.676 | 7.468 | 9.431 | 6.978 | 5.628 | 7.319 | 7.685 |
Deferred Income Tax
| -10.719 | 2.012 | 1.98 | -31.976 | 0.112 | 0.111 | 0.186 | 0 | 0 | 0 |
Stock Based Compensation
| 10.578 | 8.996 | 6.552 | 3.864 | 1.661 | 0.936 | 1.075 | 0.919 | 0.473 | 0.459 |
Change In Working Capital
| 0 | -18.073 | -34.082 | -39.288 | -26.164 | -9.667 | -22.401 | 1.507 | -0.354 | -2.887 |
Accounts Receivables
| -31.8 | 5.539 | -8.77 | -30.232 | -18.825 | -4.691 | -7.11 | -7.01 | -6.556 | 1.406 |
Inventory
| 8.21 | 6.58 | -9.41 | -9.302 | -6.7 | -11.063 | -5 | -1.49 | -5.367 | -8.198 |
Accounts Payables
| -2.372 | -0.108 | 3.26 | 3.847 | -0.635 | 4.7 | -0.06 | 0 | 0 | 0 |
Other Working Capital
| 0 | -30.084 | -19.162 | -3.601 | -0.004 | 1.387 | -10.231 | 1.507 | 0.008 | 3.905 |
Other Non Cash Items
| -3.538 | 9.588 | 16.846 | 17.8 | 5.775 | 6.115 | 18.254 | -0.156 | -303.8 | 8.811 |
Operating Cash Flow
| 14.208 | 30.917 | 24.859 | 61.978 | 6.801 | -33.528 | -60.739 | -0.587 | -0.562 | -10.193 |
Investing Activities: | ||||||||||
Investments In Property Plant And Equipment
| -10.032 | -24.364 | -33.898 | -31.22 | -21.145 | -6.234 | -1.857 | -2.426 | -1.361 | -0.51 |
Acquisitions Net
| 0 | 0 | 0 | 0 | -5.82 | 0 | 0.001 | -11.79 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 2.132 | -0.25 | 0.001 | -0.658 | -310 | 0.121 |
Investing Cash Flow
| -10.032 | -24.364 | -33.898 | -31.22 | -24.833 | -6.234 | -1.856 | -14.874 | -310 | -0.389 |
Financing Activities: | ||||||||||
Debt Repayment
| 0 | -5.173 | -3.013 | -2.014 | -15.911 | 37.225 | 1.072 | 0.1 | 11.976 | 0 |
Common Stock Issued
| 0 | 0 | 2.07 | 2.198 | 64.729 | 50.34 | 92 | -0.428 | 303.8 | 0 |
Common Stock Repurchased
| -25.479 | 0 | -0.648 | -0.737 | 0 | -6.762 | 0 | 0 | 0 | 0 |
Dividends Paid
| -1.798 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 54.914 | -0.332 | 0.814 | 0.978 | -6.35 | -2.076 | -11.43 | 19.195 | -5.2 | 10.786 |
Financing Cash Flow
| 27.637 | -5.505 | -2.199 | -1.036 | 42.468 | 78.727 | 81.642 | -0.328 | 311.476 | 10.786 |
Other Information: | ||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 31.813 | 1.048 | -11.238 | 29.722 | 24.436 | 38.965 | 19.047 | -0.914 | 0.914 | 0.204 |
Cash At End Of Period
| 136.151 | 104.338 | 103.29 | 114.528 | 84.806 | 60.37 | 21.405 | 0.126 | 1.04 | 1.199 |